Optimizing therapy in patients with pancolitis

Carmen Cuffari, Daniel H. Present, Theodore M. Bayless, Gary R. Lichtenstein

Research output: Contribution to journalReview articlepeer-review


Pancolitis affects approximately 20% to 40% of the total ulcerative colitis population and remains a therapeutic challenge for clinicians. Practitioners must focus on pancolitis when evaluating a patient for ulcerative colitis, because pancolitis is associated with more severe and fulminant disease and a higher rate of colorectal cancer and colectomy. It is imperative for clinicians to be knowledgeable in the clinical course, medications, and appropriate manner to induce and maintain clinical remission to prevent serious sequelae of the disease. The purpose of this article is to provide a review of the treatment of pancolitis for general gastroenterologists, because medical management decisions have life-long effects for this subgroup of patients.

Original languageEnglish (US)
Pages (from-to)937-946
Number of pages10
JournalInflammatory bowel diseases
Issue number10
StatePublished - Oct 2005


  • Pancolitis
  • Ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology


Dive into the research topics of 'Optimizing therapy in patients with pancolitis'. Together they form a unique fingerprint.

Cite this